<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>University of Tehran</PublisherName>
				<JournalTitle>Journal of Sciences, Islamic Republic of Iran</JournalTitle>
				<Issn>1016-1104</Issn>
				<Volume>19</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2008</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Analysis of Exon 19 and 39 of ATM Gene in Brain Tumors; Considering the P53 Accumulation</ArticleTitle>
<VernacularTitle>-</VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">31894</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
		    <Abstract>Many studies have been focused on cytogenetic and molecular genetic defects in brain tumors; therefore the role of ATM as a tumor suppressor gene in these tumors is poorly considered. In this study mutation analysis of exon 19 and 39 of ATM gene and P53 accumulation were investigated by PCR-SSCP, sequencing, and flow cytometry . Four polymorphisms including D1853N, IVS 38-8 T?C, F858L, P872T were reported for the first time in brain tumors other than medulloblastoma. Expression of P53 could be detected in more than 10% of cells in patients affected with meningioma and 4.08% and 3.46% of cells inastrocytoma and chordoma respectively. The present findings could confirm the importance of ATM gene alterations in tumor genesis of brain tumors and further investigation is essential.</Abstract>
<ArchiveCopySource DocType="pdf">https://jsciences.ut.ac.ir/article_31894_ca50333df78f2f7bd42ac688af0af3e9.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
